Ningbo Renjian Pharmaceutical Group

Ningbo Renjian Pharmaceutical Group is a prominent Chinese pharmaceutical company established in 1988 and headquartered in Ningbo, Zhejiang Province. The company specializes in the research, development, and large-scale manufacturing of biochemical APIs, chemical intermediates, and finished drug formulations. Its core product portfolio focuses on reproductive health, endocrinology, and psychiatry, featuring key products such as Human Chorionic Gonadotrophin (HCG), Menotrophin (HMG), Oxytocin, and Olanzapine. Renjian operates multiple GMP-certified production facilities through its subsidiaries, including Ningbo Renjian Chemical Pharmaceutical and Ningbo Janwell Pharmaceutical. Recognized as a National High-Tech Enterprise, the group serves both domestic and international markets with a commitment to technical innovation and high-quality pharmaceutical solutions.